Diametric Capital LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) during the fourth quarter, HoldingsChannel reports. The firm acquired 9,049 shares of the medical research company’s stock, valued at approximately $1,972,000. Charles River Laboratories International accounts for approximately 0.9% of Diametric Capital LP’s portfolio, making the […]